Zagotenemab
Zagotenemab Uses, Dosage, Side Effects, Food Interaction and all others data.
Zagotenemab is under investigation in clinical trial NCT03518073 (A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease).
| Trade Name | Zagotenemab |
| Generic | Zagotenemab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Zagotenemab
